Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tracheobronchial Secretion Removal

This study has been completed.
Sponsor:
Information provided by:
University of Milano Bicocca
ClinicalTrials.gov Identifier:
NCT00932776
First received: July 2, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
  Purpose

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.


Condition Intervention
Respiration, Artificial
Respiratory Insufficiency
Device: TBA care device
Device: Control

Study Type: Interventional

Resource links provided by NLM:


Further study details as provided by University of Milano Bicocca:

Arms Assigned Interventions
Experimental: TBA Device: TBA care device
Tracheal suction maneuvers are performed according to the indications provided by the TBA care device or to clinical parameters whichever occurs first.
Active Comparator: Control Device: Control
In this group suction maneuvers are performed according to clinical indications or on a fixed schedule whichever comes first.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • age greater than 18 years
  • presence of an endotracheal tube to provide mechanical ventilation
  • expected duration of mechanical ventilation greater than 48 hours.

Exclusion Criteria:

  • age < 18 years, pregnancy
  • presence of active bronchial bleeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00932776

Locations
Italy
A.O. San Gerardo
Monza, MB, Italy, 20052
Sponsors and Collaborators
University of Milano Bicocca
  More Information

No publications provided by University of Milano Bicocca

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00932776     History of Changes
Other Study ID Numbers: AR HSG 268
Study First Received: July 2, 2009
Last Updated: July 2, 2009
Health Authority: Italy: Ethics Committee

Additional relevant MeSH terms:
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 20, 2014